Staphylococcus epidermidis: a significant nosocomial pathogen.
Staphylococcus epidermidis is an organism formerly believed to be nonpathogenic. It is now recognized as a pathogen, causing infections on implanted devices and among immunosuppressed patients. Further, it has been involved in the development of resistance to a number of antibiotics. The epidemiology of this organism, its pathogenesis, and its treatment are important to infection control practitioners.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001434:Bacteriophage Typing; D002404:Catheterization / Q000009:adverse effects; D002557:Cerebrospinal Fluid Shunts / Q000009:adverse effects; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D004697:Endocarditis, Bacterial / Q000209:etiology; D006801:Humans; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010957:Plasmids; D011292:Premedication; D018805:Sepsis / Q000209:etiology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D013212:Staphylococcus epidermidis / Q000145:classification / Q000302:isolation & purification / Q000472:pathogenicity
D000900:Anti-Bacterial Agents